Roche launches COVID-19 test that detects and differentiates the emerging variant of interest BA.2.75

Corporate Breaking News

Home : Roche launches COVID-19 test that detects and differentiates the emerging variant of interest BA.2.75

Aug 22 2022	Roche launches COVID-19 test that detects and differentiates the emerging variant of interest BA.2.75
Roche has developed a COVID-19 test for researchers that detects the latest subvariant BA.2.75 and can differentiate it from BA.4 or BA.5 This new test is a highly accurate tool that specifically targets mutations found in the BA.2.75 subvariant - providing important epidemiological...


Source:https://www.prnewswire.com:443/news-releases/roche-launches-covid-19-test-that-detects-and-differentiates-the-emerging-variant-of-interest-ba2-75--301609342.html

Related News
» Sciatica Treatment Market Size to Grow by USD 2.52 billion, Rising Awareness about Sciatica to Boost Market Growth - Technavio » Vaderis Therapeutics AG geht an die Öffentlichkeit und gibt den Beginn einer klinischen Proof-of-Concept-Studie bei HHT bekannt